INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine, Plans First Dose Today
April 6, 2020
Plymouth Meeting, PA – INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) today, Monday, April 6th, 2020, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for INO-4800, its DNA vaccine candidate designed to prevent Coronavirus (COVID-19) infection, paving the way for Phase 1 clinical testing of INO-4800 in healthy volunteers beginning this week. The first dosing is planned for today.
Coronavirus
U.S. soldiers have worse heart health than civilians
July 7, 2019
Dallas, TX – According to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association, active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian population.
Researchers compared a group of more than 263,000 active duty Army soldiers, age 17-64, who had a health examination in 2012 with a similar group of U.S. civilians participating in the National Health and Nutrition Examination Survey (NHANES) in 2011-2012.
Less than one-third of soldiers studied had ideal blood pressure compared to about half the civilian population. (American Heart Association)
American Heart Association says Men more likely to receive bystander CPR in public than Women
November 13, 2017
Anaheim, CA – Men are more likely to receive bystander CPR in public locations compared to women, and they are more likely to survive after the life-saving measure, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
Using data from the Resuscitation Outcomes Consortium, a network of regional clinical centers in the United States and Canada studying out-of-hospital treatments of cardiac arrest and trauma, researchers analyzed 19,331 cardiac events in the home and in public.
American Heart Association reports Scientists think Public Opinion important before Human Gene Editing
October 8, 2017
Circulation: Cardiovascular Genetics Journal Report
Dallas, TX – The public should be consulted before gene editing is used to treat human embryos, according to a survey of scientists published in the American Heart Association’s journal Circulation: Cardiovascular Genetics.
“Early studies with human embryos have established the feasibility of human germline genome editing but raise complex social, ethical and legal questions,” said Kiran Musunuru, M.D., Ph.D., MPH, lead survey author and an associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
The public should be consulted before gene editing is used to treat human embryos, a survey of 300 cardiovascular researchers finds.
Magnesium may modestly lower blood pressure
July 13, 2016
American Heart Association Rapid Access Journal Report
Dallas, TX – Magnesium, an essential element in the human body, may modestly lower blood pressure, according to research published in the American Heart Association’s journal Hypertension.
Magnesium is found in whole grains, beans, nuts and green leafy vegetables.
Blood pressure cuff. (American Heart Association)
